Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$14.30 USD
+0.04 (0.28%)
Updated May 3, 2024 04:00 PM ET
After-Market: $14.28 -0.02 (-0.14%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: BMO |
3/2024 | $-0.93 | 0.00% |
Earnings Summary
For their last quarter, Urogen Pharma (URGN) reported earnings of -$0.72 per share, missing the Zacks Consensus Estimate of -$0.67 per share. This reflects a negative earnings surprise of 7.46%. Look out for URGN's next earnings release on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.93 per share, reflecting a year-over-year increase of 28.46%.
Earnings History
Price & Consensus
Zacks News for URGN
Urogen Pharma (URGN) Reports Q4 Loss, Tops Revenue Estimates
URGN: What are Zacks experts saying now?
Zacks Private Portfolio Services